China Regenerative Medicine International Limited (HKG:8158)

Market Cap	91.28M +11.1%
Revenue (ttm)	72.06M -20.5%
Net Income	27.53M +55.1%
EPS	0.09 +55.2%
Shares Out	304.25M
PE Ratio	3.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	91,500
Average Volume	309,621
Open	0.3500
Previous Close	0.3200
Day's Range	0.2950 - 0.3500
52-Week Range	0.2400 - 1.2000
Beta	-1.20
RSI	46.22
Earnings Date	Mar 27, 2026

About HKG:8158

China Regenerative Medicine International Limited, an investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China. The company operates through Aesthetic Medical and Beauty Services; and Medical Services segments. It offers medical beauty products and services; and medical products and services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicin...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 24
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8158

Financial Performance

In 2025, HKG:8158's revenue was 72.06 million, a decrease of -20.48% compared to the previous year's 90.62 million. Earnings were 27.53 million, an increase of 55.05%.